Navigation Links
Opertech Bio Receives U.S. Patent for High-Throughput Taste Evaluation Technology
Date:9/2/2014

Philadelphia, PA (PRWEB) September 02, 2014

Opertech Bio, Inc., a company that has pioneered a new highly efficient, cost effective approach to sensory evaluation, today announced the issuance of U.S. Patent No. 8,820,265 by the U.S. Patent and Trademark Office, encompassing high-throughput sensory discrimination technologies proprietary to Opertech.

“Opertech’s taste evaluation technology called Microtiter Operant Gustometer or MOG, is the first automated high throughput system for rapid characterization of taste sensory properties,” said R. Kyle Palmer, Opertech’s Chief Science Officer and inventor of the technology. “Before MOG, taste testing required many subjects, large amounts of test samples, and days to weeks for evaluation of only a few samples—all adding up to extensive expenditures in resources and dollars. MOG accomplishes the task on hundreds of samples in an afternoon, using far fewer subjects and much less sample at a fraction of the cost and with greater accuracy and consistency than previously possible,” he added.

Opertech’s proprietary technologies capture both hedonic (appetitiveness/aversiveness, or palatability) as well as chemosensory quality information from large numbers of samples in a short period of time. For example, Opertech’s MOG can be configured to accommodate a standard microtiter plate (a pharmaceutical 96-well plate) from which individual samples are dispensed/presented one at a time to a subject for evaluation with hedonic and chemosensory quality information captured/recorded for each sample in a short period of time (e.g., 96 samples can be tested and a sensory response recorded for each sample in 90 minutes or less).

The MOG Approach to Taste Evaluation

MOG is an entirely new approach to taste testing and measurement for both humans and animals. MOG is an automated high throughput system with the capacity to determine the taste characteristics of hundreds of
'/>"/>

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Opertech Bio Researchers Develop Method For High-Throughput Taste Evaluation
2. DIANA and Opertech Bio Announce Collaboration in Taste Science
3. UCSB professor receives award for graphene electronics research
4. Watsons Generic Yaz(R) Receives FDA Approval
5. Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin
6. Life Technologies Ion Personal Genome Machine Receives San Diegos CONNECT Most Innovative New Product Award
7. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
8. Intimate Bridge 2 Conception, Inc. Receives $4.3M
9. Pacific Meso Center Receives Generous Donation to First Free-Standing Mesothelioma Research Laboratory in Los Angeles
10. BioNeutral Group Receives $400,000 in Equity Financing
11. Amsterdam Molecular Therapeutics Receives US Orphan Designation for Hemophilia B Gene Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... RESEARCH TRIANGLE PARK, N.C. , May 1, 2015 ... that Roger Jeffs , Ph.D., President and Co-Chief Executive ... on the company,s business at the Deutsche Bank 40 th ... . The presentation will take place on ... can be accessed via a live webcast on the United ...
(Date:4/30/2015)...  Roka Bioscience, Inc. (NASDAQ: ROKA ), a ... for the detection of foodborne pathogens, announced plans to ... 2015 on May 7, 2015 after the close of ... host a conference call at 4:30 p.m. Eastern Time ... financial results. During the conference call, material information concerning ...
(Date:4/30/2015)... 2015 Cytokinetics, Incorporated (Nasdaq: CYTK) reported total ... were $4.4 million, compared to $8.0 million during the same ... quarter was $8.9 million, or $0.23 per basic and diluted ... same period in 2014, of $8.7 million, or $0.27 per ... cash, cash equivalents and investments totaled $117.5 million. , ...
(Date:4/30/2015)... April 30, 2015 Nitto Avecia, ... announces its increased capacity and production capability to ... client variety and service fulfillment continues to drive ... improve process throughput capacities. , In ... installed downstream process equipment at its Milford, MA ...
Breaking Biology Technology:Roka Bioscience to Report First Quarter 2015 Financial Results On May 7, 2015 2Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 2Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 3Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 4Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 5Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 6Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 7Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 8Biotechnology Manufacturer Nitto Avecia Expands Capacity to Meet Client Demand 2
... Intercell AG (VSE: ICLL) today announced that it ... U.S. Food and Drug Administration,s (FDA) approval of IXIARO(R), ... (JE). The initial target for use of Intercell,s vaccine ... U.S. market - will be adult travelers and military ...
... DOR BioPharma, Inc. (OTC Bulletin Board: DORB) (DOR or ... financial results for 2008. DOR,s revenues for 2008 were ... The increase was due primarily to progress with ... of certain research and development milestones with our subcontractors. ...
... Va., March 31 - Innocoll, Inc. announced that its ... application for its CollaRx(TM) Lidocaine Sponge for the management ... year 13 million patients worldwide suffer from chronic wounds ... 35 percent of all chronic wounds do not ...
Cached Biology Technology:Intercell to Host Conference Call and Webcast Today on FDA Approval of IXIARO(R) Japanese Encephalitis Vaccine 2Intercell to Host Conference Call and Webcast Today on FDA Approval of IXIARO(R) Japanese Encephalitis Vaccine 3DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 2DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 3DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 4DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 5Innocoll, Inc. Files 510 (k) Application for CollaRx Lidocaine Sponge 2
(Date:4/1/2015)... 1, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces the second ... is underway to early access pre-order customers. ... at retail outlets including Walmart, Target, AT&T, Dunkin, Donuts, ... was accepted at all outlets and very easy to ...
(Date:3/31/2015)... 31, 2015  Elephant Talk Communications Corp. (NYSE MKT: ... of Software Defined Network Architecture (ET Software DNA® 2.0) ... of approximately $20.4 million for the year ended December ... for the year ended December 31, 2013. ... had completed its multi-year transition away from its legacy ...
(Date:3/30/2015)... and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ) has announced ... in Automotive Sector 2014-2018" report to their offering. ... market in Automotive Sector to grow at a CAGR ... recognition is the ability of a device to identify ... recognition technology can be 2D-based or 3D-based. It uses ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
... Institute and MIT have engineered yeast that can improve ... component to making biofuels a significant part of the ... additive to improve gasoline combustibility, ethanol is often touted ... crisis. But there are significant obstacles to producing ethanol. ...
... manipulate the brain's perception of jaw movement while words ... importance of non-auditory sensory cues in the brain's control ... and David Ostry of McGill University and appear in ... published by Cell Press. , When we speak, ...
... Institute have identified a novel biomarker for brain tumors ... play when the tumor spreads or comes back after ... cerebrospinal fluid of patients with malignant astrocytoma and mediates ... of Clinical Cancer Research. , The biomarker, ...
Cached Biology News:Engineered yeast speeds ethanol production 2Sensory feedback during speech: The brain attunes to more than just sound 2Newly identified biomarker detects and regulates spread of brain tumors 2
... The new MALDI O-TOF creates a ... on an orthogonal platform that has been ... the University of Manitoba. , As the ... orthogonal design and collisional cooling, the prOTOF ...
Rat Aortic Endothelial Cells (RAOEC) (>500,000 cells)...
... miVac Duo is suitable for use with ... organic solvents through to water and some ... centrifugal concentrator capable of removing water and ... formats including tubes, microplates, vials and round ...
37-1A9...
Biology Products: